A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy.
- Author:
Hua-ying ZHOU
1
;
Yu-huang ZHENG
;
Chun-ying ZHANG
;
Pei-pei DING
;
Wen ZOU
Author Information
1. AIDS Research Laboratory, Division of Infectious Diseases, Second Xiangya Hospital, Central South University, Changsha 410011, China.
- Publication Type:Clinical Trial
- MeSH:
Acquired Immunodeficiency Syndrome;
drug therapy;
immunology;
virology;
Adolescent;
Adult;
Antiretroviral Therapy, Highly Active;
adverse effects;
CD4 Lymphocyte Count;
Child;
Didanosine;
administration & dosage;
Female;
HIV-1;
Humans;
Immunophenotyping;
Male;
Middle Aged;
Nevirapine;
administration & dosage;
RNA, Viral;
blood;
Stavudine;
administration & dosage;
T-Lymphocytes;
immunology
- From:
Chinese Medical Journal
2005;118(7):609-611
- CountryChina
- Language:English
